255 related articles for article (PubMed ID: 26155400)
1. Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival.
Di Lullo G; Marcatti M; Heltai S; Brunetto E; Tresoldi C; Bondanza A; Bonini C; Ponzoni M; Tonon G; Ciceri F; Bordignon C; Protti MP
Oncoimmunology; 2015 May; 4(5):e1005460. PubMed ID: 26155400
[TBL] [Abstract][Full Text] [Related]
2. Th22 Cells Promote Osteoclast Differentiation
Miyazaki Y; Nakayamada S; Kubo S; Nakano K; Iwata S; Miyagawa I; Ma X; Trimova G; Sakata K; Tanaka Y
Front Immunol; 2018; 9():2901. PubMed ID: 30619268
[TBL] [Abstract][Full Text] [Related]
3. Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease.
Truchetet ME; Brembilla NC; Montanari E; Allanore Y; Chizzolini C
Arthritis Res Ther; 2011; 13(5):R166. PubMed ID: 21996293
[TBL] [Abstract][Full Text] [Related]
4. PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients.
Costa F; Vescovini R; Marchica V; Storti P; Notarfranchi L; Dalla Palma B; Toscani D; Burroughs-Garcia J; Catarozzo MT; Sammarelli G; Giuliani N
Front Immunol; 2020; 11():613007. PubMed ID: 33488620
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory effect of human bone marrow-derived mesenchymal stromal/stem cells on peripheral blood T cells from rheumatoid arthritis patients.
Pedrosa M; Gomes J; Laranjeira P; Duarte C; Pedreiro S; Antunes B; Ribeiro T; Santos F; Martinho A; Fardilha M; Domingues MR; Abecasis M; P da Silva JA; Paiva A
J Tissue Eng Regen Med; 2020 Jan; 14(1):16-28. PubMed ID: 31502378
[TBL] [Abstract][Full Text] [Related]
6. Plasmacytoid Dendritic Cells in Patients with MGUS and Multiple Myeloma.
Knight A; Rihova L; Kralova R; Penka M; Adam Z; Pour L; Piskacek M; Hajek R
J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34442012
[TBL] [Abstract][Full Text] [Related]
7. Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma.
Calcinotto A; Ponzoni M; Ria R; Grioni M; Cattaneo E; Villa I; Sabrina Bertilaccio MT; Chesi M; Rubinacci A; Tonon G; Bergsagel PL; Vacca A; Bellone M
Oncoimmunology; 2015 Jun; 4(6):e1008850. PubMed ID: 26155424
[TBL] [Abstract][Full Text] [Related]
8. Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma.
Prabhala RH; Pelluru D; Fulciniti M; Prabhala HK; Nanjappa P; Song W; Pai C; Amin S; Tai YT; Richardson PG; Ghobrial IM; Treon SP; Daley JF; Anderson KC; Kutok JL; Munshi NC
Blood; 2010 Jul; 115(26):5385-92. PubMed ID: 20395418
[TBL] [Abstract][Full Text] [Related]
9. Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma.
Wang M; Chen P; Jia Y; He N; Li D; Ji C; Ma D
Oncotarget; 2015 Jul; 6(20):17958-67. PubMed ID: 26255628
[TBL] [Abstract][Full Text] [Related]
10. Cytokine and chemokine profiles in multiple myeloma; significance of stromal interaction and correlation of IL-8 production with disease progression.
Kline M; Donovan K; Wellik L; Lust C; Jin W; Moon-Tasson L; Xiong Y; Witzig TE; Kumar S; Rajkumar SV; Lust JA
Leuk Res; 2007 May; 31(5):591-8. PubMed ID: 16879867
[TBL] [Abstract][Full Text] [Related]
11. Th22 cells as well as Th17 cells expand differentially in patients with early-stage and late-stage myelodysplastic syndrome.
Shao LL; Zhang L; Hou Y; Yu S; Liu XG; Huang XY; Sun YX; Tian T; He N; Ma DX; Peng J; Hou M
PLoS One; 2012; 7(12):e51339. PubMed ID: 23236476
[TBL] [Abstract][Full Text] [Related]
12. Disrupted balance of CD4
Wang Q; Li J; Yu TS; Liu Y; Li K; Liu S; Liu Y; Feng Q; Zhang L; Li GS; Shao LL; Peng J; Hou M; Liu XG
Int J Biol Sci; 2019; 15(13):2798-2814. PubMed ID: 31853219
[TBL] [Abstract][Full Text] [Related]
13. Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells.
Laranjeira P; Pedrosa M; Pedreiro S; Gomes J; Martinho A; Antunes B; Ribeiro T; Santos F; Trindade H; Paiva A
Stem Cell Res Ther; 2015 Jan; 6(1):3. PubMed ID: 25559824
[TBL] [Abstract][Full Text] [Related]
14. Cytokine/Chemokine responses in activated CD4+ and CD8+ T cells isolated from peripheral blood, bone marrow, and axillary lymph nodes during acute simian immunodeficiency virus infection.
Kenway-Lynch CS; Das A; Lackner AA; Pahar B
J Virol; 2014 Aug; 88(16):9442-57. PubMed ID: 24920807
[TBL] [Abstract][Full Text] [Related]
15. Mass Cytometry Discovers Two Discrete Subsets of CD39
Marsh-Wakefield F; Kruzins A; McGuire HM; Yang S; Bryant C; Fazekas de St Groth B; Nassif N; Byrne SN; Gibson J; Brown C; Larsen S; McCulloch D; Boyle R; Clark G; Joshua D; Ho PJ; Vuckovic S
Front Immunol; 2019; 10():1596. PubMed ID: 31428081
[TBL] [Abstract][Full Text] [Related]
16. Interferon-γ and tumor necrosis factor-α promote the ability of human placenta-derived mesenchymal stromal cells to express programmed death ligand-2 and induce the differentiation of CD4(+)interleukin-10(+) and CD8(+)interleukin-10(+)Treg subsets.
Li H; Wang W; Wang G; Hou Y; Xu F; Liu R; Wang F; Xue J; Hu T; Luan X
Cytotherapy; 2015 Nov; 17(11):1560-71. PubMed ID: 26432559
[TBL] [Abstract][Full Text] [Related]
17. The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients.
Cao Y; Luetkens T; Kobold S; Hildebrandt Y; Gordic M; Lajmi N; Meyer S; Bartels K; Zander AR; Bokemeyer C; Kröger N; Atanackovic D
Exp Hematol; 2010 Oct; 38(10):860-7. PubMed ID: 20619313
[TBL] [Abstract][Full Text] [Related]
18. Role of IL-22- and TNF-α-producing Th22 cells in uveitis patients with Behcet's disease.
Sugita S; Kawazoe Y; Imai A; Kawaguchi T; Horie S; Keino H; Takahashi M; Mochizuki M
J Immunol; 2013 Jun; 190(11):5799-808. PubMed ID: 23630362
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
[TBL] [Abstract][Full Text] [Related]
20. The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia.
Sun YX; Kong HL; Liu CF; Yu S; Tian T; Ma DX; Ji CY
Hum Immunol; 2014 Feb; 75(2):113-8. PubMed ID: 24269703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
